J M Bell

Summary

Affiliation: South Australia
Country: Australia

Publications

  1. pmc Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates
    J M Bell
    National Antimicrobial Resistance Surveillance Program, Women s and Children s Hospital, North Adelaide, Australia
    J Clin Microbiol 36:2187-90. 1998
  2. pmc Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001
    J M Bell
    Microbiology and Infectious Diseases Department, Women s and Children s Hospital, Adelaide, Australia
    Antimicrob Agents Chemother 47:3989-93. 2003
  3. ncbi request reprint Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific
    Jan M Bell
    Department of Microbiology and Infectious Diseases, Women s and Children s Hospital, 72 King William Road, North Adelaide, SA 5006, Australia
    J Antimicrob Chemother 51:339-45. 2003
  4. ncbi request reprint In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998-199
    Jan M Bell
    Women s and Children s Hospital, Adelaide, Australia
    Diagn Microbiol Infect Dis 43:315-8. 2002
  5. ncbi request reprint Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99)
    Jan M Bell
    Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide, South Australia
    Diagn Microbiol Infect Dis 42:193-8. 2002
  6. ncbi request reprint SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South Africa
    Jan Bell
    Microbiology and Infectious Diseases, Women s and Children s Hospital, Adelaide, South Australia
    Commun Dis Intell 27:S61-6. 2003
  7. ncbi request reprint Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756
    J M Bell
    Adelaide, Australia
    Int J Antimicrob Agents 19:125-32. 2002
  8. pmc Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveil
    Jan M Bell
    Women s and Children s Hospital, Adelaide, South Australia 5006, Australia
    J Clin Microbiol 45:1478-82. 2007
  9. ncbi request reprint Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia. Pneumococcal Study Group
    J D Turnidge
    Women s and Children s Hospital, Adelaide, SA
    Med J Aust 170:152-5. 1999
  10. ncbi request reprint Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents
    J M Bell
    Department of Microbiology and Infectious Diseases, Women's and Children's Hospital, Adelaide, South Australia
    Pathology 33:53-60. 2001

Collaborators

Detail Information

Publications35

  1. pmc Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates
    J M Bell
    National Antimicrobial Resistance Surveillance Program, Women s and Children s Hospital, North Adelaide, Australia
    J Clin Microbiol 36:2187-90. 1998
    ..Rapid and accurate methods are essential, because laboratory-based surveillance is critical in programs for the detection, control, and prevention of the transmission of glycopeptide-resistant enterococci...
  2. pmc Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001
    J M Bell
    Microbiology and Infectious Diseases Department, Women s and Children s Hospital, Adelaide, Australia
    Antimicrob Agents Chemother 47:3989-93. 2003
    ..A cefepime MIC above 0.25 microg/ml had the highest sensitivity (100%) and specificity (74%) for predicting the presence of an ESBL...
  3. ncbi request reprint Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific
    Jan M Bell
    Department of Microbiology and Infectious Diseases, Women s and Children s Hospital, 72 King William Road, North Adelaide, SA 5006, Australia
    J Antimicrob Chemother 51:339-45. 2003
    ..0.12-2 mg/L (1 mg/L) for S. pneumoniae and 0.25-2 mg/L (1 mg/L) for Streptococcus spp. There was no difference in linezolid susceptibility between countries or between multiresistant and susceptible strains of each species monitored...
  4. ncbi request reprint In vitro assessment of gatifloxacin spectrum and potency tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from the Asia-Western Pacific component of the SENTRY antimicrobial surveillance program (1998-199
    Jan M Bell
    Women s and Children s Hospital, Adelaide, Australia
    Diagn Microbiol Infect Dis 43:315-8. 2002
    ..pneumoniae (3 of which were resistant); in three strains of H. influenzae (MIC >/= 0.12 microg/mL), and 2 M. catarrhalis (MIC > 2 microg/mL)...
  5. ncbi request reprint Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99)
    Jan M Bell
    Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide, South Australia
    Diagn Microbiol Infect Dis 42:193-8. 2002
    ..The best coverage against ESBL-producing isolates was obtained with imipenem (0% resistance), followed by amikacin (6% resistance)...
  6. ncbi request reprint SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South Africa
    Jan Bell
    Microbiology and Infectious Diseases, Women s and Children s Hospital, Adelaide, South Australia
    Commun Dis Intell 27:S61-6. 2003
    ..The data generated from SENTRY allows Australia to compare our antimicrobial resistance patterns and trends with our regional neighbours...
  7. ncbi request reprint Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756
    J M Bell
    Adelaide, Australia
    Int J Antimicrob Agents 19:125-32. 2002
    ..8%. Both H. influenzae and M. catarrhalis isolates were uniformly susceptible to the new desfluoroquinolone and tested fluoroquinolones...
  8. pmc Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveil
    Jan M Bell
    Women s and Children s Hospital, Adelaide, South Australia 5006, Australia
    J Clin Microbiol 45:1478-82. 2007
    ..coli and K. pneumoniae from the Asia-Pacific region harbor important beta-lactamases, and a positive screening test alone should be sufficient grounds to report resistance to extended-spectrum cephalosporins in this region...
  9. ncbi request reprint Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in Australia. Pneumococcal Study Group
    J D Turnidge
    Women s and Children s Hospital, Adelaide, SA
    Med J Aust 170:152-5. 1999
    ..To examine the prevalence of resistance in Streptococcus pneumoniae to key antimicrobials in Australia during 1997...
  10. ncbi request reprint Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents
    J M Bell
    Department of Microbiology and Infectious Diseases, Women's and Children's Hospital, Adelaide, South Australia
    Pathology 33:53-60. 2001
    ..Enterococci, Bacillus species, Burkholderia cepacia and Stenotrophomonas maltophilia were predicably resistant. Cefepime has a spectrum of activity almost as broad as that of the carbapenems...
  11. ncbi request reprint Identification of plasmid-mediated extended-spectrum and AmpC beta-lactamases in Enterobacter spp. isolated from dogs
    Hanna E Sidjabat
    School of Veterinary Science, The University of Queensland, Brisbane, QLD 4072, and Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide, SA, Australia
    J Med Microbiol 56:426-34. 2007
    ..Therefore, Enterobacter isolated from opportunistic infections in dogs may be an important reservoir of plasmid-mediated resistance genes, which could potentially be spread to other members of the Enterobacteriaceae...
  12. doi request reprint Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008)
    Jan M Bell
    Microbiology and Infectious Diseases Directorate, SA Pathology, Women s and Children s Hospital, Adelaide, South Australia
    Pathology 42:470-3. 2010
    ..To assess in vitro activity and spectrum of daptomycin, a new lipopeptide antimicrobial, against contemporary isolates of Gram positive pathogens in Australia and New Zealand in 2008...
  13. ncbi request reprint Methicillin-resistant Staphylococcal aureus evolution in Australia over 35 years
    J D Turnidge
    Department of Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide, South Australia, Australia
    Microb Drug Resist 6:223-9. 2000
    ..It has a similar antibiogram to the western strains, but an entirely different epidemiology, resembling that currently being experienced in parts of New Zealand, and associated with patients of south Pacific island origin...
  14. pmc Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using clinical and laboratory standards institute methods: a SENTRY antimicrobial surveillance program report
    Jan M Bell
    SA Pathology at the Women s and Children s Hospital, North Adelaide, South Australia, Australia
    J Clin Microbiol 47:2187-93. 2009
    ..The proposed interpretive criteria were highly accurate, with <or=0.7% very major (falsely susceptible) and <or=1.0% major (falsely resistant) errors, respectively...
  15. pmc High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999
    Jan M Bell
    Department of Microbiology and Infectious Diseases, Women s and Children s Hospital, North Adelaide SA 5006, Australia
    Antimicrob Agents Chemother 46:879-81. 2002
    ..No vancomycin-intermediate strains were detected, and no strains were resistant to linezolid or quinupristin-dalfopristin. MORSA strains are a very common cause of infection in hospitalized patients in the APAC region...
  16. pmc aac(6')-Ib-cr genotyping by simultaneous high-resolution melting analyses of an unlabeled probe and full-length amplicon
    Jan M Bell
    SA Pathology, Women s and Children s Hospital, 72 King William Rd, North Adelaide, SA 5006, Australia
    Antimicrob Agents Chemother 54:1378-80. 2010
    ..Our genotyping assay uses the combined information of simultaneously acquired high-resolution melting data from an unlabeled probe and the full-length amplicon...
  17. ncbi request reprint Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989-1999
    Graeme R Nimmo
    Microbiology Department, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba 4102, Australia
    Microb Drug Resist 9:155-60. 2003
    ..The proportion of nmMRSA increased to modest levels in the other cities. In eastern cities, this was due to the appearance of strains closely related to nmMRSA seen in other countries of the southwestern Pacific...
  18. ncbi request reprint Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004)
    Douglas J Biedenbach
    JMI Laboratories, 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317, USA
    Int J Antimicrob Agents 30:143-9. 2007
    ..Daptomycin was demonstrated to have excellent in vitro activity when tested against Gram-positive isolates collected from Asia-Pacific countries, including hVISA strains...
  19. ncbi request reprint Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance
    Graeme R Nimmo
    Division of Microbiology, Queensland Health Pathology Service, Central Laboratory, Herston
    Commun Dis Intell Q Rep 31:288-96. 2007
    ..Further investigation is warranted as reductions in prevalence would reduce morbidity, mortality and healthcare costs...
  20. pmc Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene
    Rodrigo E Mendes
    Antimicrob Agents Chemother 52:798-9. 2008
  21. ncbi request reprint Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: report from the Australian Group on Antimicrobial Resistance
    Keryn J Christiansen
    Department of Microbiology and Infectious Diseases, PathWest Laboratory Medicine, Royal Perth Hospital, Western Australia
    Commun Dis Intell 31:392-7. 2007
    ....
  22. ncbi request reprint Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005: report from the Australian Group on Antimicrobial Resistance
    Thomas Gottlieb
    Department of Microbiology and Infectious Diseases, Concord Hospital, Concord, New South Wales
    Commun Dis Intell 32:242-9. 2008
    ..6% to 5.4%. After a rapid emergence and rise in resistance between 1989 and 1999, recent studies have documented a continuing rise in resistance to all non-beta-lactams except trimethoprim-sulphamethoxazole...
  23. ncbi request reprint Identification of bla(CMY-7) and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia
    Hanna E Sidjabat
    School of Veterinary Science, The University of Queensland, Brisbane, QLD 4072, Australia
    J Antimicrob Chemother 57:840-8. 2006
    ..To determine clonality and identify plasmid-mediated resistance genes in 11 multidrug-resistant Escherichia coli (MDREC) isolates associated with opportunistic infections in hospitalized dogs in Australia...
  24. ncbi request reprint Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes
    Anton Y Peleg
    J Antimicrob Chemother 57:794-5. 2006
  25. ncbi request reprint Fifteen years of surveillance by the Australian Group for Antimicrobial Resistance (AGAR)
    Graeme R Nimmo
    Queensland Health Pathology Services, Princess Alexandra Hospital, Brisbane, Queensland
    Commun Dis Intell 27:S47-54. 2003
    ..The recent extension of membership to include more private pathology laboratories may provide the opportunity to conduct more representative community based surveys...
  26. ncbi request reprint Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002)
    Ronald N Jones
    The JONES Group JMI Laboratories, North Liberty, IA, USA
    Diagn Microbiol Infect Dis 49:289-94. 2004
    ....
  27. pmc Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia
    Geoffrey W Coombs
    Gram positive Bacteria Typing and Research Unit, Royal Perth Hospital, Australia
    J Clin Microbiol 42:4735-43. 2004
    ..These findings provide support for the acquisition of SCCmec by multiple lineages of S. aureus. They also confirm that both hospital and community strains of MRSA are now common in nonhospitalized patients throughout Australia...
  28. ncbi request reprint Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage
    Michael Watson
    New South Wales Pneumococcal Reference Laboratory, Department of Microbiology, Children s Hospital at Westmead, New South Wales
    Commun Dis Intell Q Rep 27:478-87. 2003
    ....
  29. pmc Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community
    Keiko Okuma
    Department of Bacteriology, Juntendo University, Tokyo, Japan
    J Clin Microbiol 40:4289-94. 2002
    ..They multiplied much faster than health-care-associated MRSA and were resistant to fewer non-beta-lactam antibiotics. They seem to have been derived from more diverse S. aureus populations than health-care-associated MRSA strains...
  30. ncbi request reprint Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program
    Michael Watson
    The NSW Pneumococcal Reference Laboratory, Department of Microbiology, The Children s Hospital at Westmead, Westmead, New South Wales
    Commun Dis Intell 28:455-64. 2004
    ....
  31. ncbi request reprint Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002)
    Yoichi Hirakata
    Department of Laboratory Medicine, School of Medicine, Nagasaki University, Nagasaki 852 8501, Japan
    Diagn Microbiol Infect Dis 52:323-9. 2005
    ..Imipenem retained activity against all ESBL-producing strains. Organisms expressing ESBLs are widely distributed in the Asia-Pacific region, although prevalence rates vary significantly...
  32. ncbi request reprint Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia
    Anton Y Peleg
    Infectious Diseases and Microbiology Department, The Alfred Hospital, Melbourne, Australia
    Clin Infect Dis 41:1549-56. 2005
    ..We describe the first outbreak in Australia of infection and/or colonization with gram-negative pathogens carrying the MBL gene blaIMP-4...
  33. pmc OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia
    Anton Y Peleg
    Antimicrob Agents Chemother 50:399-400. 2006
  34. ncbi request reprint Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia
    Anton Y Peleg
    Infectious Diseases Unit, Alfred Hospital, Melbourne, Victoria, Australia
    Infect Control Hosp Epidemiol 27:759-61. 2006
    ..Selected isolates were of the same clonal type, and no genes encoding carbapenemases were identified...
  35. ncbi request reprint Activity of a peptide deformylase inhibitor LBM415 (NVP PDF-713) tested against recent clinical isolates from Japan
    Jan M Bell
    J Antimicrob Chemother 55:276-8. 2005